Advertisement

Topics

Options Shift Paradigm of Locally Advanced HER2+ Breast Cancer

11:50 EST 18 Feb 2019 | OncLive

Theresa Shao, MD, discusses the neoadjuvant and adjuvant findings with pertuzumab as well as the adjuvant use of neratinib in patients with locally advanced HER2-positive breast cancer.

Original Article: Options Shift Paradigm of Locally Advanced HER2+ Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Options Shift Paradigm of Locally Advanced HER2+ Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement